TuHURA corrects pro forma financials for Kineta merger; FY2025 net loss $34.6M

TuHURA Biosciences, Inc./NV

Corrected unaudited pro forma combined net loss for FY2025: $34.5M ($34.6M attributable to common), EPS -$0.66.
Prior 8-K filed April 8, 2026 contained errors; this amendment replaces Exhibit 99.1 entirely.
Merger with Kineta closed June 30, 2025; Kineta stockholders received 3.998M shares (7.6% of combined entity).
TuHURA issued 4.76M shares + warrants in a June 2025 PIPE for net proceeds of $11.5M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.